⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6929619 | 0.73 | — | — | |
| SCHEMBL4016818 | 0.54 | — | — | |
| SCHEMBL30900645 | 0.44 | — | — | |
| SCHEMBL1585970 | 0.44 | — | — | |
| SCHEMBL29354445 | 0.38 | — | — | |
| SCHEMBL6559802 | 0.38 | — | — | |
| SCHEMBL30254807 | 0.38 | — | — | |
| Methane SCHEMBL17599294 | 0.38 | — | — | |
| SCHEMBL38654827 | 0.38 | — | — | |
| SCHEMBL29889134 | 0.38 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030144249-A1 | Use of organophosphorous compounds for producing a medicament for treating infections | JOMAA PHARMAKA GMBH (DE) | 2003-07-31 | — | — | US | disclosed |
| WO-2002078714-A1 | FORMULATIONS WHICH ARE RESISTANT TO GASTRIC JUICE AND ARE USED TO APPLY ANTI-INFECTIVE COMPOUNDS INHIBITING THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND THE SALTS AND ESTERS OF THE SAME | JOMAA PHARMAKA GMBH (DE) | 2002-10-10 | — | — | WO | disclosed |